These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3291697)

  • 1. Vasoactive intestinal peptide as a coronary vasodilator.
    Smitherman TC; Dehmer GJ; Said SI
    Ann N Y Acad Sci; 1988; 527():421-30. PubMed ID: 3291697
    [No Abstract]   [Full Text] [Related]  

  • 2. Action and localization of vasoactive intestinal peptide in the coronary circulation: evidence for nonadrenergic, noncholinergic coronary regulation.
    Brum JM; Bove AA; Sufan Q; Reilly W; Go VL
    J Am Coll Cardiol; 1986 Feb; 7(2):406-13. PubMed ID: 3944362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide in the heart.
    Forssmann WG; Triepel J; Daffner C; Heym C; Cuevas P; Noble MI; Yanaihara N
    Ann N Y Acad Sci; 1988; 527():405-20. PubMed ID: 3291696
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
    Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ
    Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
    Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
    Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
    Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
    J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of vasoactive intestinal peptide to stimulate aldosterone production.
    Enyedi P; Szabó B; Spät A
    Acta Physiol Hung; 1983; 61(1-2):77-9. PubMed ID: 6637524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide.
    Said SI
    J Endocrinol Invest; 1986 Apr; 9(2):191-200. PubMed ID: 2872248
    [No Abstract]   [Full Text] [Related]  

  • 10. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries.
    Grant S; Lutz EM; McPhaden AR; Wadsworth RM
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasoactive intestinal peptide (VIP)-induced pulmonary vasodilation mediated by EDRF/NO in isolated perfused rat lungs].
    Iwabuchi S; Ono S; Funata J; Hoshikawa Y; Ueda S; Ashino Y; Tanita T; Fujimura S; Koike K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Mar; 33(3):262-7. PubMed ID: 7739167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans.
    Smitherman TC; Popma JJ; Said SI; Krejs GJ; Dehmer GJ
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1254-62. PubMed ID: 2801984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of vasoactive intestinal polypeptide in the parasympathetic vasodilatation of the rat masseter muscle.
    Niioka T; Ishii H; Izumi H
    Arch Oral Biol; 2009 Oct; 54(10):909-16. PubMed ID: 19647228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardia.
    Markos F; Snow HM
    Eur J Appl Physiol; 2006 Nov; 98(4):419-22. PubMed ID: 16896725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mechanical stimulation, substance P and vasoactive intestinal polypeptide on the electrical and mechanical activities of circular smooth muscles from pig coronary arteries contracted with acetylcholine: role of endothelium.
    Beny JL; Brunet PC; Huggel H
    Pharmacology; 1986; 33(2):61-8. PubMed ID: 2426721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vasoactive intestinal peptide and peptide histidine isoleucine in the cerebral circulation.
    Edvinsson L; McCulloch J; Kelly PA; Tuor UI
    Ann N Y Acad Sci; 1988; 527():378-92. PubMed ID: 2898910
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide and acetylcholine are responsible for neurovasodilation in the head of the cat.
    Bevan JA; Brayden JE; Buga GM; Moskowitz MA; Said SI
    J Hypertens Suppl; 1984 Dec; 2(3):S427-9. PubMed ID: 6599693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide.
    Andersson PO; Bloom SR; Mellander S
    J Physiol; 1984 May; 350():209-24. PubMed ID: 6747850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vasoactive intestinal polypeptide infusion on cardiovascular function in man.
    Frase LL; Gaffney FA; Lane LL; Blomqvist CG; Krejs GJ
    Front Horm Res; 1984; 12():127-8. PubMed ID: 11540860
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasoactive intestinal peptide: cardiovascular effects.
    Henning RJ; Sawmiller DR
    Cardiovasc Res; 2001 Jan; 49(1):27-37. PubMed ID: 11121793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.